Jackson B. Coole

Jackson B. Coole

Auto-generated profile, based on publicly available information

Jackson B. Coole

Department of Bioengineering, Rice University, Houston, Texas

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
LJLingbo Jin
Lingbo Jin
YTYubo Tang
Yubo Tang
YWYicheng Wu
Yicheng Wu
JCJackson B. Coole
Jackson B. Coole
MTMelody T. Tan
Melody T. Tan
AVAshok Veeraraghavan
Ashok Veeraraghavan
Significance: Traditional microscopy suffers from a fixed trade-off between depth-of-field (DOF) and spatial resolution—the higher the desired spatial resolution, the narrower the DOF. We present DeepDOF, a computational microscope that allows us to break free from this constraint and achieve >5× larger DOF while retaining cellular-resolution imaging—obviating the need for z-scanning and significantly reducing the time needed for imaging. The key ingredients that allow this advance are 1) an optimized phase mask placed at the microscope aperture; and 2) a deep-learning-based algorithm that turns sensor data into high-resolution, large-DOF images. DeepDOF offers an inexpensive means for fast and slide-free histology, suited for improving tissue sampling during intraoperative assessment and in resource-constrained settings.

21 June 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
KKKathryn A. Kundrod
Kathryn A. Kundrod
MBMaria Barra
Maria Barra
AWAlexis Wilkinson
Alexis Wilkinson
CSChelsey A. Smith
Chelsey A. Smith
MNMary E. Natoli
Mary E. Natoli
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
High-risk human papillomavirus (HPV) DNA testing is widely acknowledged as the most sensitive cervical cancer screening method but has limited availability in resource-limited settings, where the burden of cervical cancer is highest. Recently, HPV DNA tests have been developed for use in resource-limited settings, but they remain too costly for widespread use and require instruments that are often limited to centralized laboratories. To help meet the global need for low-cost cervical cancer screening, we developed a prototype, sample-to-answer, point-of-care test for HPV16 and HPV18 DNA. Our test relies on isothermal DNA amplification and lateral flow detection, two technologies that reduce the need for complex instrumentation. We integrated all test components into a low-cost, manufacturable platform, and performance of the integrated test was evaluated with synthetic samples, provider-collected clinical samples in a high-resource setting in the United States, and self-collected clinical samples in a low-resource setting in Mozambique. We demonstrated a clinically relevant limit of detection of 1000 HPV16 or HPV18 DNA copies per test. The test requires six user steps, yields results in 45 min, and can be performed using a benchtop instrument and minicentrifuge by minimally trained personnel. The projected per-test cost is <$5, and the projected instrumentation cost is <$1000. These results show the feasibility of a sample-to-answer, point-of-care HPV DNA test. With the inclusion of other HPV types, this test has the potential to fill a critical gap for decentralized and globally accessible cervical cancer screening.

6 September 2022 in Biomedical Optics Express
Verified
Journal Article
Closed access
JCJackson B. Coole
Jackson B. Coole
DBDavid Brenes
David Brenes
JPJúlio César Possati-Resende
Júlio César Possati-Resende
MAMárcio Antoniazzi
Márcio Antoniazzi
BFBruno de Oliveira Fonseca
Bruno de Oliveira Fonseca
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
Cervical cancer remains a leading cause of cancer death among women in low-and middle-income countries. Globally, cervical cancer prevention programs are hampered by a lack of resources, infrastructure, and personnel. We describe a multimodal mobile colposcope (MMC) designed to diagnose precancerous cervical lesions at the point-of-care without the need for biopsy. The MMC integrates two complementary imaging systems: 1) a commercially available colposcope and 2) a high speed, high-resolution, fiber-optic microendoscope (HRME). Combining these two image modalities allows, for the first time, the ability to locate suspicious cervical lesions using widefield imaging and then to obtain co-registered high-resolution images across an entire lesion. The MMC overcomes limitations of high-resolution imaging alone; widefield imaging can be used to guide the placement of the high-resolution imaging probe at clinically suspicious regions and co-registered, mosaicked high-resolution images effectively increase the field of view of high-resolution imaging. Representative data collected from patients referred for colposcopy at Barretos Cancer Hospital in Brazil, including 22,800 high resolution images and 9,900 colposcope images, illustrate the ability of the MMC to identify abnormal cervical regions, image suspicious areas with subcellular resolution, and distinguish between high-grade and low-grade dysplasia.

16 January 2025 in Cancer Prevention Research
Verified
Journal Article
Open access
RMRuchika Mitbander
Ruchika Mitbander
DBDavid Brenes
David Brenes
JCJackson B. Coole
Jackson B. Coole
AKAlex Kortum
Alex Kortum
IVImran S. Vohra
Imran S. Vohra
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
Oral cancer is a major global health problem. It is commonly diagnosed at an advanced stage, although often preceded by clinically visible oral mucosal lesions, termed oral potentially malignant disorders, which are associated with an increased risk of oral cancer development. There is an unmet clinical need for effective screening tools to assist front-line healthcare providers to determine which patients should be referred to an oral cancer specialist for evaluation. This study reports the development and evaluation of the mobile detection of oral cancer (mDOC) imaging system and an automated algorithm that generates a referral recommendation from mDOC images. mDOC is a smartphone-based autofluorescence and white light imaging tool that captures images of the oral cavity. Data were collected using mDOC from a total of 332 oral sites in a study of 29 healthy volunteers and 120 patients seeking care for an oral mucosal lesion. A multimodal image classification algorithm was developed to generate a recommendation of “refer” or “do not refer” from mDOC images using expert clinical referral decision as the ground truth label. A referral algorithm was developed using cross-validation methods on 80% of the dataset and then retrained and evaluated on a separate holdout test set. Referral decisions generated in the holdout test set had a sensitivity of 93.9% and a specificity of 79.3% with respect to expert clinical referral decisions. The mDOC system has the potential to be utilized in community physicians’ and dentists’ offices to help identify patients who need further evaluation by an oral cancer specialist. Prevention Relevance: Our research focuses on improving the early detection of oral precancers/cancers in primary dental care settings with a novel mobile platform that can be used by front-line providers to aid in assessing whether a patient has an oral mucosal condition that requires further follow-up with an oral cancer specialist.

20 March 2024 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
DBDavid Brenes
David Brenes
MSMila P. Salcedo
Mila P. Salcedo
JCJackson B. Coole
Jackson B. Coole
YMYajur Maker
Yajur Maker
AKAlex Kortum
Alex Kortum
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
Objective: Early detection and treatment of cervical precancers can prevent disease progression. However, in low-resource communities with a high incidence of cervical cancer, high equipment costs and a shortage of specialists hinder preventative strategies. This manuscript presents a low-cost multiscale in vivo optical imaging system coupled with a computer-aided diagnostic system that could enable accurate, real-time diagnosis of high-grade cervical precancers. Methods: The system combines portable colposcopy and high-resolution endomicroscopy (HRME) to acquire spatially registered widefield and microscopy videos. A multiscale imaging fusion network (MSFN) was developed to identify cervical intraepithelial neoplasia grade 2 or more severe (CIN 2+). The MSFN automatically identifies and segments the ectocervix and lesions from colposcopy images, extracts nuclear morphology features from HRME videos, and integrates the colposcopy and HRME information. Results: With a threshold value set to achieve sensitivity equal to clinical impression (0.98 [p = 1.0]), the MSFN achieved a significantly higher specificity than clinical impression (0.75 vs. 0.43, p = 0.000006). Conclusion: Our findings show that multiscale optical imaging of the cervix allows the highly sensitive and specific detection of high-grade precancers. Significance: The multiscale imaging system and MSFN could facilitate the accurate, real-time diagnosis of cervical precancers in low-resource settings.

1 January 2023 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
JCJackson B. Coole
Jackson B. Coole
DBDavid Brenes
David Brenes
RMRuchika Mitbander
Ruchika Mitbander
IVImran Vohra
Imran Vohra
HHHuayu Hou
Huayu Hou
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
SignificanceDespite recent advances in multimodal optical imaging, oral imaging systems often do not provide real-time actionable guidance to the clinician who is making biopsy and treatment decisions.AimWe demonstrate a low-cost, portable active biopsy guidance system (ABGS) that uses multimodal optical imaging with deep learning to directly project cancer risk and biopsy guidance maps onto oral mucosa in real time.ApproachCancer risk maps are generated based on widefield autofluorescence images and projected onto the at-risk tissue using a digital light projector. Microendoscopy images are obtained from at-risk areas, and multimodal image data are used to calculate a biopsy guidance map, which is projected onto tissue.ResultsRepresentative patient examples highlight clinically actionable visualizations provided in real time during an imaging procedure. Results show multimodal imaging with cancer risk and biopsy guidance map projection offers a versatile, quantitative, and precise tool to guide biopsy site selection and improve early detection of oral cancers.ConclusionsThe ABGS provides direct visible guidance to identify early lesions and locate appropriate sites to biopsy within those lesions. This represents an opportunity to translate multimodal imaging into real-time clinically actionable visualizations to help improve patient outcomes.